View Author
model patient 8 model hcv-rna treatment response hepatitis hepatitis c measurement prediction virological response week 12 pa index index week 12 algorithm value virological pa indices algorithm therapy 12 weeks 12 model 0-w model limit ribavirin study nonsustained virological response hcv-rna measurements accuracy baseline method curve hepatitis c virus roc curve model score interferon 4 model score indices gender genotype hcv-rna measurement 48 weeks difference combination therapy virus peginterferon alfa -2b 4 model vs 0.02 · bmi week 12 measurement hepatology body mass index peginterferon combination hepatitis c patients sample speci ficity table lukasiewicz result speci õ model pegylated interferon outcome publishing blackwell factor threshold treatment outcome analysis 50 iu /ml fi rst month hepatol 8 model vs performance nonsustained interferon alfa -2b fi rst 12 week 12. polymerase chain reaction
1 Most Recent Publications
|
Prediction of nonSVR to therapy with pegylated interferon-α2a and ribavirin in chronic hepatitis C genotype 1 patients after 4, 8 and 12 weeks of treatment
(Article)
Lukasiewicz, E. Gorfine, M. Freedman, L.S. Pawlotsky, J.M. Schalm, S.W. Ferrari, C. Zeuzem, S. Neumann, A.U. |
2010-05-01
|